Back to Search Start Over

Green synthesis of gold nanoparticles in an animal model of chronic wound induced with Resiquimod.

Authors :
Mendes C
Zaccaron RP
Casagrande LR
Venturini LM
da Costa C
Lima IR
Wermuth TB
Arcaro S
Feuser PE
Lock Silveira PC
Source :
Journal of drug targeting [J Drug Target] 2024 Nov; Vol. 32 (9), pp. 1086-1100. Date of Electronic Publication: 2024 Jul 12.
Publication Year :
2024

Abstract

Cost-effective strategies for the treatment of chronic wounds must be developed. The green synthesis of gold nanoparticles (GNPs) it is possible to guarantee a lower toxicity in biological tissues and greater safety of applicability, in addition to adding the effects of nanoparticles (NPs) to those of extracts. The objective of this study was to evaluate the effects of treatment with biosynthesized GNPs in a chronic wound model. Wistar rats were distributed into 7 groups: Acute Wound (AW); Chronic wound (CW); CW + GNPs-Açaí; CW + GNPs-DB; CW + AV-GNPs; CW + SafGel <superscript>®</superscript> ; CW + 660 nm laser. The chronic injury model was induced with topically applied Resiquimod for 6 days. Treatments were then initated on the fourteenth day after the last application of Resiquimod and carried out daily for ten days. The proposed therapies with GNPs were able to significantly reduce the inflammatory score and increase the rate of wound contraction. In histology, there was a reduction in the inflammatory infiltrate and increased gene expression of fibronectin and type III collagen, mainly in the CW + AV-GNPs group. The therapies were able to reduce pro-inflammatory cytokines, increase anti-inflammatory cytokines, and reduce oxidative stress. The results demonstrated that the effects of GNPs appear to complement those of the extracts, thereby enhancing the tissue repair process.

Details

Language :
English
ISSN :
1029-2330
Volume :
32
Issue :
9
Database :
MEDLINE
Journal :
Journal of drug targeting
Publication Type :
Academic Journal
Accession number :
38980282
Full Text :
https://doi.org/10.1080/1061186X.2024.2373304